-
Thursday, 11/28/2024
CIBER Congress: 10 YEARS ADVANCING TOGETHER IN HEALTH
CIBER Congress: 10 YEARS ADVANCING TOGETHER IN HEALTHDate: Wednesday, November 27thVenue: Valencia Conference Centrethe CIBER Congress: 10 Years Advancing Together in Health, a unique event bringing together over 1,500 researchers, managers, associations, companies, and young talents committed to biomedical research.In addition to the scientific program, this congress is a remarkable opportunity to strengthen your network and boost your projects. Renowned companies like MSD and Johnson & Johnson will also be present to enrich the event. -
Friday, 11/15/2024
PNEUMONIA WORLD DAY
Today we celebrate the Pnemonia World Day
Barcelona, November 14th
Aula Magna, Faculty of Medicine, University of Barcelona, Spain
-
Monday, 11/11/2024
Homi-Lung team in the ISICIP Congress
During this year’s ISICIP Congress, being held in Barcelona on 7-8 November, the Homi-Lung team came together to discuss the latest developments in our European project. Most of the participants connected to the meeting online, while the local team in Barcelona was deeply involved in the congress celebration. The Homi-Lung promotional materials were showcased during the event.
-
Friday, 11/01/2024
Welcome Marcial Cariqueo, PharmD, to Our Research Team!
Welcome Marcial Cariqueo, PharmD, to Our Research Team!
We are happy to welcome Marcial Cariqueo, PharmD, an experienced critical care pharmacist and academic from Chile, as our new Research Support Officer. Marcial will coordinate the “Surveillance Study of Respiratory Pathogens in Adults Hospitalized for SARI Across Europe (idDRIVE),” led by Prof. Antoni Torres.
With his skills in critical care pharmacology and experience in population pharmacokinetics, Marcial brings valuable expertise to our team. His dedication to evidence-based practices, teamwork, and improving patient care through new ideas will help us reach the study’s goals.
-
Thursday, 10/31/2024
Aina García-Planchart, Internship Residence, Stucom Barcelona
Internship Residence, Stucom Barcelona
Internship Residence, Stucom Barcelona
Aina Garcia Planchart, a student in residence to obtain her Clinical and Biomedical Laboratory
Technician degree, is currently completing her professional training at IDIBAPS.From September 2024 to March 2025, she will support laboratory activities, assist researchers, and gain essential hands-on experience to prepare for her career in biomedical sciences. -
Thursday, 10/31/2024
New fellow from Italy
Filippo Sartori, MD
Resident in a High-Dependency Unit at Verona University (Italy).
Staying at IDIBAPS from October 2024 until March 2025.
During his period at IDIBAPS, he will focus on critical care in respiratory medicine, especially on mechanical ventilation and the role of pronation in the outcome of ARF and ARDS. He will be involved in the ARDS-ECMO animal model experiment.
-
Monday, 10/28/2024
New ARISTOS’ fellow
Dr. Viviane Oliveira, from Brazil, staying in the research group from 2024 to 2027
Biologist, MSc. in Experimental Pathology, and Ph.D. in Science by the University of São Paulo / Brazil.
Dr. Viviane Oliveira has been awarded the prestigious ARISTOS fellowship. This esteemed grant, funded by the European Union's Horizon Europe research and innovation programme –under the Marie Sklodowska-Curie Actions (MSCA), is designed to support highly-qualified postdoctoral researchers with opportunities for international, intersectoral, and interdisciplinary research. Known for its highly competitive selection process, the ARISTOS grant provides not only financial support but also access to a vast network of research and training opportunities across CIBER and European institutions.With the ARISTOS fellowship, Dr. Oliveira will embark on a three-year research journey at our group focusing in define a safety protocol to apply Phages to treat Ventilator-Associated Pneumonia (VAP), namely on understanding biofilm growth on the surface of endotracheal tubes and efficiency of phage’s treatments, alone and in combination with antibiotics.
The project's impact reaches beyond the scientific realm, as its findings could aid in developing new treatments for VAP, enhancing patient outcome and tackling the issue of antibiotic resistance.
-
Monday, 09/16/2024
Prof. A. Torres Receives the ERS Lifetime Achievement Award in Respiratory Infections
Prof. A. Torres Receives the ERS Lifetime Achievement Award in Respiratory Infections
We are very honored as research fellows in Prof. Torres’ group to announce that last Saturday, he received the ERS Lifetime Achievement Award in Respiratory Infections, granted by the European Respiratory Society. For more information about this award, please follow the link: ERS Award Winners 2024.
-
Sunday, 09/01/2024
Lucia Alessandra Pasqua, fellow from Italy
Lucia Alessandra Pasqua, MD,
Resident in Anesthesiology and Intensive Care Medicine at University Magna Graecia of Catanzaro, Italy.
Staying in IDIBAPS from September 2024 to February 2025.
During her fellowship, she will be involved on research into respiratory diseases using animal models, with the goal of advancing our clinical understanding of these conditions and exploring new, evidence-based therapeutic approaches; also in studies on VAP (ventilator-associated-pneumonia).
This experience represents a significant opportunity for her, as it allows her to complement her clinical training with in-depth research work in an internationally renowned setting. Through this project, she is gaining specialized skills in experimental methodologies and translational research.
She is passionate about bridging the gap between research and patient care, aiming to bring scientific advancements from the lab to clinical practice to improve patient outcomes.
-
Friday, 08/16/2024
Launching of the HOMILUNG project website
Last June we launched the website of the Homi-Lung (www.homilung.com) a European project deciphering the causal relationship between cardiovascular and respiratory diseases progression and the immune and microbiome alterations observed during and after pneumonia. It has started in 2024 and it is expected to finish in 2029. Our research group IDIBAPS- Ciberes and Hospital Clinic (Lead by Prof. Antoni Torres) is mainly involved in WP2 (Prospective cohorts and patients need), WP6 (Causal link between pneumonia-induced dysbiosis and CVRD progression in preclinical models) and leads the WP7 (dissemination, communication, and exploitation).
